| Subject |
Oneness Biotech Co., Ltd. receives a European patent on the producing recombinant glycoproteins with modified glycosylation. |
- Date of occurrence of the event:2022/01/20
- Company name:ONENESS BIOTECH CO., LTD.
- Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
- Reciprocal shareholding ratios:NA
- Cause of occurrence:
The Company has been informed by the patent agency that the methods for glycan modification on recombinant protein , has been granted a European patent entitled ”METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION”under the patent number EP 3119882 B1.
- Countermeasures:None
- Any other matters that need to be specified:None
|
